Filing Details
- Accession Number:
- 0001209191-20-050564
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-15 18:31:19
- Reporting Period:
- 2020-09-14
- Accepted Time:
- 2020-09-15 18:31:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1649989 | Outlook Therapeutics Inc. | OTLK | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1204059 | H Randy Thurman | C/O Outlook Therapeutics, Inc. 4260 Us Route 1 Monmouth Junction NJ 08852 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-09-14 | 10,000 | $0.62 | 11,875 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.62 to $0.625, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
- Reflects a 1-for-8 reverse stock split effected by the Issuer on March 15, 2019 (the "Split Date"). The Reporting Person's previous ownership of 15,000 shares of common stock was adjusted to 1,875 shares of Common Stock on the Split Date.
Billionaire Hedge Funds
